Evaluating statistical approaches to leverage large clinical datasets for uncovering therapeutic and adverse medication effects.

Author: BeckCole, CarrollRobert J, ChoiLeena, DennyJoshua C, MosleyJonathan D, RodenDan M, Van DriestSara L

Paper Details 
Original Abstract of the Article :
Phenome-wide association studies (PheWAS) have been used to discover many genotype-phenotype relationships and have the potential to identify therapeutic and adverse drug outcomes using longitudinal data within electronic health records (EHRs). However, the statistical methods for PheWAS applied to ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6129383/

データ提供:米国国立医学図書館(NLM)

Harnessing Big Data: Unveiling the Secrets of Medications

The field of pharmacoepidemiology is rapidly evolving, leveraging the power of big data to uncover the therapeutic and adverse effects of medications. This article delves into the use of phenome-wide association studies (PheWAS) for identifying drug-related outcomes using longitudinal data from electronic health records (EHRs). The authors highlight the potential of PheWAS for discovering new drug-related associations and for enhancing our understanding of medication safety and efficacy.

PheWAS: A Compass in the Desert of Medication Data

The authors emphasize the need for robust statistical methods to analyze longitudinal EHR data for PheWAS studies. They highlight the challenges associated with analyzing this complex data and the importance of developing appropriate statistical approaches to ensure the reliability and validity of PheWAS findings. The authors also underscore the potential of PheWAS for improving patient safety and for optimizing medication use.

Medication Safety: A Journey Through the Desert of Data

This article underscores the importance of leveraging big data to improve medication safety and efficacy. The authors highlight the potential of PheWAS for identifying unexpected drug-related effects and for uncovering new therapeutic uses of existing medications. The study also emphasizes the need for ongoing research to refine statistical methods for analyzing longitudinal EHR data and to ensure the reliable and valid interpretation of PheWAS findings.

Dr.Camel's Conclusion

The use of PheWAS for analyzing longitudinal EHR data represents a significant advancement in the field of pharmacoepidemiology. The study highlights the potential of this approach for uncovering new drug-related associations and for improving medication safety and efficacy. Further research is essential to optimize statistical methods for analyzing this complex data and to ensure the reliable and valid interpretation of PheWAS findings.

Date :
  1. Date Completed 2019-09-23
  2. Date Revised 2022-01-29
Further Info :

Pubmed ID

29912272

DOI: Digital Object Identifier

PMC6129383

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.